MedservRegis p.l.c. provided earnings guidance for the year ended December 31, 2023. The group's unaudited revenues for 2023 are anticipated to be in the region of EUR 73 million, an increase of 9% compared to the EUR 66.9 million achieved in 2022 and an increase of 13.2% against the revenue forecast disclosed in the 2022 Updated Financial Analysis Summary.
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
0.6 EUR | 0.00% | 0.00% | -3.23% |
Jan. 31 | MedservRegis p.l.c. Provides Earnings Guidance for the Year Ended December 31, 2023 | CI |
2023 | MedservRegis p.l.c. Reports Earnings Results for the Half Year Ended June 30, 2023 | CI |
Annual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-3.23% | 65.1M | |
+24.30% | 31.49B | |
+21.02% | 23.83B | |
-14.91% | 23.03B | |
-3.80% | 12.27B | |
+4.34% | 10.85B | |
+45.92% | 9.64B | |
+3.71% | 9.39B | |
+3.13% | 7.96B | |
-22.98% | 7.55B |
- Stock Market
- Equities
- MDS Stock
- News MedservRegis p.l.c.
- MedservRegis p.l.c. Provides Earnings Guidance for the Year Ended December 31, 2023